These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 20632253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.
    Maione TE, Gray GS, Hunt AJ, Sharpe RJ.
    Cancer Res; 1991 Apr 15; 51(8):2077-83. PubMed ID: 1706960
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Apr 15; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 6. Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis.
    Yamaguchi K, Ogawa K, Katsube T, Shimao K, Konno S, Shimakawa T, Yoshimatsu K, Naritaka Y, Yagawa H, Hirose K.
    Anticancer Res; 2005 Apr 15; 25(2A):847-51. PubMed ID: 15868918
    [Abstract] [Full Text] [Related]

  • 7. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A, Folkman J.
    Drug Resist Updat; 2010 Apr 15; 13(1-2):16-28. PubMed ID: 20061178
    [Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparins and angiogenesis.
    Norrby K.
    APMIS; 2006 Feb 15; 114(2):79-102. PubMed ID: 16519745
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis--a new target for future therapy.
    Pandya NM, Dhalla NS, Santani DD.
    Vascul Pharmacol; 2006 May 15; 44(5):265-74. PubMed ID: 16545987
    [Abstract] [Full Text] [Related]

  • 14. Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8.
    Martí F, Bertran E, Llucià M, Villén E, Peiró M, Garcia J, Rueda F.
    J Leukoc Biol; 2002 Sep 15; 72(3):590-7. PubMed ID: 12223528
    [Abstract] [Full Text] [Related]

  • 15. The role of angiogenesis in solid tumours: an overview.
    Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K.
    Eur J Intern Med; 2009 Nov 15; 20(7):663-71. PubMed ID: 19818284
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.
    Li Y, Jin Y, Chen H, Jie G, Tobelem G, Caen JP, Han ZC.
    Cancer Biother Radiopharm; 2003 Oct 15; 18(5):829-40. PubMed ID: 14629831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.